Clinical Trial Update: An Observational Study to Assess Optive MEGA-3 (OM3) on Dry Eye Symptoms and Quality of Life of Adult Participants With Mild to Moderate Dry Eye Disease (DED)

View source ↗

Summary

This clinical trial update reports the completion of an observational study evaluating the effect of Optive MEGA-3 (OM3) on dry eye symptoms and quality of life…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• Optive MEGA-3 (OM3) (Omega-3 fatty acid-containing ocular product)

Snippet

Sponsor: AbbVie | Conditions: Dry Eye | Status: COMPLETED